EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

The Actin‐Binding Prolyl‐Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery

Anna Sternberg iD, Jennifer Lynne Borger iD, Mathilda Thies, Anja Matena iD, Mike Blueggel iD, Bianca E Kamba, Christine Beuck iD, Farnusch Kaschani iD, Markus Kaiser iD, Peter Bayer iD

Proteins: Structure, Function, and Bioinformatics · 2025

DOI: 10.1002/prot.26807 ↗

At a glance

Journal article in Proteins: Structure, Function, and Bioinformatics, 2025. Written by Anna Sternberg and 9 co-authors. Institution: Structural and Medicinal Biochemistry, Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany. Major MEDLINE topics: Actins, Peptidylprolyl Isomerase. 62 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The human peptidyl‐prolyl‐ cis / trans isomerases (PPIases), Parvulin 14 and Parvulin 17, accelerate the cis / trans isomerization of Xaa‐Pro moieties within protein sequences. By modulating the respective binding interfaces of their target proteins, they play a crucial role in determining the fate of their substrates within the cell. Although both enzymes share the same amino acid sequence, they have different cellular functions. This difference is due to a 25 residue N‐terminal extension present in Par17 but absent in Par14. Using activity assays, NMR spectroscopy, and mass spectrometry, we demonstrate that the N‐terminal extension of Par17 determines substrate selectivity by an intramolecular allosteric mechanism and exhibits a target‐binding motif that interacts with actin.

Subjects

MeSH terms (MEDLINE)

ActinsPeptidylprolyl IsomeraseHumansSubstrate SpecificityProtein BindingAllosteric RegulationBinding SitesModels, MolecularAmino Acid SequenceRecombinant ProteinsNIMA-Interacting Peptidylprolyl IsomeraseProtein DomainsNuclear Magnetic Resonance, Biomolecular

Substances

ActinsRecombinant ProteinsNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl Isomerase

Authors and institutions

  • Structural and Medicinal Biochemistry, Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
  • Quality Management Consultant at validAID, Bonn, Germany.
  • TUM, Bioverfahrenstechnik, Straubing, Germany.
  • Consultant Sustainability Services, München, Germany.
  • Chemical Biology, Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
  • Analytics Core Facility Essen (ACE), Center for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.

ORCID profiles: Anna Sternberg, Jennifer Lynne Borger, Anja Matena, Mike Blueggel, Christine Beuck, Farnusch Kaschani, Markus Kaiser, Peter Bayer

Cite

APA

Sternberg, A., Borger, J. L., Thies, M., Matena, A., Blueggel, M., Kamba, B. E., Beuck, C., Kaschani, F., Kaiser, M., & Bayer, P. (2025). The Actin‐Binding Prolyl‐Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery. Proteins: Structure, Function, and Bioinformatics. https://doi.org/10.1002/prot.26807

Vancouver

Sternberg A, Borger JL, Thies M, Matena A, Blueggel M, Kamba BE, et al. The Actin‐Binding Prolyl‐Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery. Proteins: Structure, Function, and Bioinformatics. 2025. doi:10.1002/prot.26807

BibTeX
@article{Sternberg2025,
  author = {Sternberg, Anna and Borger, Jennifer Lynne and Thies, Mathilda and Matena, Anja and Blueggel, Mike and Kamba, Bianca E and Beuck, Christine and Kaschani, Farnusch and Kaiser, Markus and Bayer, Peter},
  title = {The Actin‐Binding Prolyl‐Isomerase Par17 Sustains Its Substrate Selectivity by Interdomain Allostery},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2025},
  doi = {10.1002/prot.26807}
}
Start for free →